A quick test to determine the right antibiotics for urinary tract infections
Rapid, equitable, lateral flow-based antibiotic susceptibility testing for urinary tract infections
['FUNDING_SBIR_1'] · LATDE DIAGNOSTICS CORP. · NIH-11006225
This study is working on a quick and fair test to help doctors find the best antibiotics for treating urinary tract infections, making it easier for patients to get the right treatment faster, especially in places with fewer resources.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LATDE DIAGNOSTICS CORP. (nih funded) |
| Locations | 1 site (NORTHAMPTON, UNITED STATES) |
| Trial ID | NIH-11006225 on ClinicalTrials.gov |
What this research studies
This research aims to develop a rapid and equitable test for antibiotic susceptibility in urinary tract infections (UTIs), which affects millions of patients each year. The test is designed to be used in outpatient and resource-limited settings, allowing healthcare providers to quickly identify the most effective antibiotics for treatment. By reducing the time it takes to get results, this approach seeks to minimize unnecessary delays in therapy and the risk of complications from UTIs. The goal is to improve patient outcomes while also addressing the growing issue of antibiotic resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing urinary tract infections, particularly women and those from low socioeconomic backgrounds.
Not a fit: Patients with UTIs who are already receiving effective treatment or those with conditions unrelated to antibiotic susceptibility may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective treatment for patients suffering from urinary tract infections.
How similar studies have performed: Other research has shown promise in developing rapid antibiotic susceptibility tests, but this specific approach is novel and aims to address significant gaps in current UTI diagnostics.
Where this research is happening
NORTHAMPTON, UNITED STATES
- LATDE DIAGNOSTICS CORP. — NORTHAMPTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MELZER, EMILY S — LATDE DIAGNOSTICS CORP.
- Study coordinator: MELZER, EMILY S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.